Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Adipose Tissue Dysfunction Occurs Independently of Obesity in Adipocyte-Specific Oncostatin Receptor Knockout Mice.

Stephens JM., Bailey JL., Hang H., Rittell V., Dietrich MA., Mynatt RL.

Animal Study, published in Obesity (Silver Spring) (2018) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Obesity (Silver Spring) (2018)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
30226002
PMCID
PMC6146404
DOI
10.1002/oby.22254
Citations
14

Abstract (original English)

Objective This study examined the phenotypic effects of adipocyte-specific oncostatin M receptor (OSMR) loss in chow-fed mice. Methods Chow-fed adipocyte-specific OSMR knockout (FKO) mice and littermate OSMR fl/fl controls were studied. Tissue weights, insulin sensitivity, adipokine production, and stromal cell immunophenotypes were assessed in epididymal fat (eWAT); serum adipokine production was also assessed. In vitro, adipocytes were treated with oncostatin M, and adipokine gene expression was assessed. Results Body weights, fasting blood glucose levels, and eWAT weights did not differ between genotypes. However, the eWAT of OSMR FKO mice was modestly less responsive to insulin stimulation than that of OSMR fl/fl mice. Notably, significant increases in adipokines, including C-reactive protein, lipocalin 2, intercellular adhesion molecule-1, and insulinlike growth factor binding protein 6, were observed in the eWAT of OSMR FKO mice. In addition, significant increases in fetuin A and intercellular adhesion molecule-1 were detected in OSMR FKO serum. Flow cytometry revealed a significant increase in leukocyte number and modest, but not statistically significant, increases in B cells and T cells in the eWAT of OSMR FKO mice. Conclusions The chow-fed OSMR FKO mice exhibited adipose tissue dysfunction and increased proinflammatory adipokine production. These results suggest that

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdipose TissueAnimalsMaleMiceMice, KnockoutOncostatin M

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.